Standard InChI: InChI=1S/C26H30O4/c1-18(2)6-5-7-19(3)8-14-23-25(30-4)17-15-22(26(23)29)24(28)16-11-20-9-12-21(27)13-10-20/h6,8-13,15-17,27,29H,5,7,14H2,1-4H3/b16-11+,19-8+
2.Park JY, Jeong HJ, Kim YM, Park SJ, Rho MC, Park KH, Ryu YB, Lee WS.. (2011) Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition., 21 (18):[PMID:21824777][10.1016/j.bmcl.2011.06.130]
3.Li JL, Gao LX, Meng FW, Tang CL, Zhang RJ, Li JY, Luo C, Li J, Zhao WM.. (2015) PTP1B inhibitors from stems of Angelica keiskei (Ashitaba)., 25 (10):[PMID:25891102][10.1016/j.bmcl.2015.04.003]
4.Mizar P, Arya R, Kim T, Cha S, Ryu KS, Yeo WS, Bae T, Kim DW, Park KH, Kim KK, Lee SS.. (2018) Total Synthesis of Xanthoangelol B and Its Various Fragments: Toward Inhibition of Virulence Factor Production of Staphylococcus aureus., 61 (23):[PMID:30388007][10.1021/acs.jmedchem.8b01012]
5.Liu Y,Liang C,Xin L,Ren X,Tian L,Ju X,Li H,Wang Y,Zhao Q,Liu H,Cao W,Xie X,Zhang D,Wang Y,Jian Y. (2020) The development of Coronavirus 3C-Like protease (3CL) inhibitors from 2010 to 2020., 206 [PMID:32810751][10.1016/j.ejmech.2020.112711]
6.Dan W, Dai J.. (2020) Recent developments of chalcones as potential antibacterial agents in medicinal chemistry., 187 [PMID:31877539][10.1016/j.ejmech.2019.111980]